...
机译:吡咯洛并[1,2-b] [1,2,5]苯并噻二氮杂s(PBTDs)通过干扰慢性粒细胞性白血病患者细胞中的Akt-mTOR信号传导和bax:bcl-2比例调节来发挥其抗增殖活性。
Departments of Experimental Medicine and Biochemical Sciences;
|Departments of Experimental Medicine and Biochemical Sciences;
||Hematology, University of Rome “
Tor Vergata”
, Rome;
Departments of Experimental Medicine and Biochemical Sciences;
Department of Medicinal Chemistry and Technologies, Sapienza University of Rome, Rome, Italy;
Hematology, University of Rome “
Tor Vergata”
, Rome;
Hematology, University of Rome “
Tor Vergata”
, Rome;
机译:吡咯并[1,2-b] [1,2,5]苯并噻二氮杂ze(PBTDs)通过干扰来自慢性粒细胞性白血病患者的细胞中的Akt-mTOR信号传导和bax:bcl-2比调节来发挥其抗增殖活性
机译:吡咯洛并(1,2-b)(1,2,5)苯并噻二氮卓类(PBTD)通过干扰Akt-mTOR信号传导和bax:bcl-2比例调节慢性髓样白血病患者的细胞发挥其抗增殖活性。
机译:吡咯洛并(1,2-b)(1,2,5)苯并噻二氮卓类(PBTD)通过干扰Akt-mTOR信号传导和bax:bcl-2比例调节慢性髓样白血病患者的细胞发挥其抗增殖活性。
机译:S9一种新型的抗癌药物通过干扰PI3K-Akt-mTOR信号传导和微管细胞骨架来发挥其抗增殖活性
机译:吡咯并[1,2-b] [1,2,5]苯并噻二氮杂ze(PBTDs)通过干扰来自慢性粒细胞性白血病患者的细胞中的Akt-mTOR信号传导和bax:bcl-2比调节来发挥其抗增殖活性